|
- Combined Drug Therapy Prevents Progression of Prostate Enlargement Helps Men at High Risk Avoid
Surgery (NIDDK, December 17, 2003)
- Young Adult Fitness Protects Heart Health in Middle Age (NHLBI, December 16, 2003)
- Combination, Order of Anti-HIV Drugs Make a Difference in First-time Recipients (NIAID, December 10, 2003)
- Early Treatment of Blinding Eye Disease in Infants Can Prevent Severe Vision Loss (NEI, December 8, 2003)
- Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children
(Taylor JA et al. JAMA. 2003 Dec 3;290(21):2824-2830.)
- Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of Schizophrenia: A
Randomized Controlled Trial. (Rosenheck R et al. JAMA. 2003 Nov 26;290(20):2693-702.)
- NIAID Ebola Vaccine Enters Human Trial (NIAID, November 18, 2003)
- Public Access Defibrillation by Trained Community Volunteers Increases Survival for Victims
of Cardiac Arrest (NHLBI, November 11, 2003)
- A Randomized Trial of Letrozole in Postmenopausal Women After Five Years of Tamoxifen Therapy
for Early-Stage Breast cancer. (Goss PE et al. N Engl J Med. 2003 Nov 6;349(19):1793-802.)
- Childhood Cardiovascular Risk Factors and Carotid Vascular Changes in Adulthood: The
Bogalusa Heart Study. (Li S et al. JAMA. 2003 Nov 5;290(17):2271-6.)
- A Milestone for ClinicalTrials.gov Web Site (FDA, October 27, 2003)
- NHLBI Study Finds Hostility, Impatience Increase Hypertension Risk (NHLBI, October 21, 2003)
- New Treatment Significantly Improves Long-term Outlook For Breast Cancer Survivors (NCI, October 09, 2003)
- The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal
Osteoporosis. (Black DM et al. N Engl J Med. 2003 Sep 20 [Epub ahead of print].)
- The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis. (Finkelstein
JS et al. N Engl J Med. 2003 Sep 20 [Epub ahead of print].)
- Nevirapine Sustains Advantage Over AZT During Breastfeeding Period (NIAID, September 11, 2003)
- NHLBI Study Finds Moderate Physical Activity Promotes Weight Loss as well as Intense
Exercise (NHLBI, September 09, 2003)
- NIAID Opens Innovative Treatment Study for West Nile Virus (NIAID, September 08, 2003)
- Office-Based Therapy for Opiate Addiction Successful (NIDA, September 03, 2003)
- Treatment Interruption Shows No Benefit in Drug-Resistant HIV Infection (NIAID, August 27, 2003)
- NHLBI Study Tests Novel Ways To Help Americans Keep Weight Off (NHLBI, July 14, 2003)
- Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal
Women (Chlebowski RT et al. JAMA. 2003 Jun 25;289(24):3243-53.)
- Study of Heart Disease Patients Treated for Depression and Low Social Support Finds No Survival
Benefit but Significant Improvement in Depression and Social Functioning (NHLBI, June 17, 2003)
- Oral Insulin Does Not Prevent Type 1 Diabetes (NIDDK, June 15, 2003)
- Antifungal Drug Helps Kids with Immune Disorder Avoid Hospitalization (NIAID, June 11, 2003)
- Aspirin as Effective as Ticlopidine in African American Antiplatelet Stroke Prevention
Study (NINDS, June 10, 2003)
- Women Benefit More from Quitting Smoking than Men (NHLBI, June 2, 2003)
- Donor Immune Cells Attack Metastatic Breast Cancer (NCI, June 1, 2003)
- Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and
South America (Lalezari JP et al. N Engl J Med 2003 May 29;348(22):2175-85)
- Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and
Australia (Lazzarin A et al. N Engl J Med 2003 May 29;348(22):2186-95)
- Rates of Dementia Increase Among Older Women on Combination Hormone Therapy (NIA, NHLBI, May 27, 2003)
- Landmark Cooperative Federal Study Defines the Role of Lung Surgery in the Treatment of
Severe Emphysema (NHLBI, May 20, 2003)
- Genetics Home Reference (NLM, May 15, 2003)
- NICHD Study To Test Surgical Technique to Repair Spinal Defect Before Birth (April, 25, 2003)
- NHLBI Study Finds All-in-one Approach to Lifestyle Changes Effectively Lowers Blood Pressure (April 22, 2003)
- Study Boosts Confidence in Potential Screening Tool For Alzheimer's Disease (NIMH, April 22, 2003)
- Twins, Close Brothers, Sisters Sought for Study of Causes Of Rheumatic Diseases
Such as Lupus, Sclerosis, Myopathy (NIEHS, April 21, 2003)
- Television Watching and Other Sedentary Behaviors in Relation to Risk of Obesity
and Type 2 Diabetes Mellitus in Women (Hu FB et al. JAMA. 2003;289:1785-1791)
- Multicenter Study of Hydroxyurea (MSH) in Patients With Sickle Cell Anemia (NHLBI, April 1, 2003)
- Treatment for Minor Depression (NIMH, NCCAM, ODS, March 21, 2003)
- Effects of Estrogen plus Progestin on Health-Related Quality of Life. (Hays J et
al. N Engl J Med. 2003 Mar 17 [epub ahead of print])
- Important Interim Results from a Phase III, Randomized, Double-Blind Comparison of Three
Protease-Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection
(AACTG Protocol A5095) (NIAID, March 13, 2003)
- Low Dose Warfarin Prevents Recurrence of Blood Clots - NHLBI Stops Study (NHLBI, February 24, 2003)
- NHLBI Study Finds Possible New Indicator of Heart Disease Risk (NHLBI, February 12, 2003)
- Cognitive Abilities Increase Significantly With Time in Most Prematurely Born Children (NINDS, February 11, 2003)
- Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable
risk factors. (Karlson EW et al. Am J Med 2003 Feb 1;114(2):93-98)
- Anger Expression and Risk of Stroke and Coronary Heart Disease Among Male Health Professionals
(Eng PM et al. Psychosom Med 2003 Jan-Feb;65(1):100-10.)
- NIH Study Shows MRI Provides Faster, More Accurate Way To Diagnose Heart Attacks (NHLBI, January 29, 2003)
- A Prospective Study of Sleep Duration and Coronary Heart Disease in Women. (Ayas NT et al.
Arch Intern Med 2003 Jan 27;163(2):205-9)
- FDA Places Temporary Halt On Gene Therapy Trials Using Retroviral Vectors In Blood Stem Cells
- Frequency of Light-to-Moderate Drinking Reduces Heart Disease Risk in Men (NIAAA, NHLBI, January 8, 2003)
- A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis. (Miller DH et al.; International
Natalizumab Multiple Sclerosis Trial Group. N Engl J Med 2003 Jan 2;348(1):15-23)